“…The gelation mechanism by chemical crosslinking (for gelatin and hyaluronic acid) and ionic (for chitosan and alginate) are not suitable for the bioactivity of cell-loading bioink, and the inappropriate degradation rate (for fibrin and collagen) also shows an unfavorable servicing. Previously, a series of Silk fibroin (SF) products gained much attention for application and they were studied as a protein polymer for biomedical applications, for instance, in the enzyme immobilization matrix [24], wound dressing [25], vascular prosthesis [26], and artificial grafts [27], due to its similar components to the extracellular matrix (ECM), low-cost, tunable mechanical properties, controllable degradation, and good biocompatibility [28,29]. The timeline of the development of SF based bioink in 3D printing technology [30,31,32,33,34,35,36] over the past 30 years has witnessed great research and application value for the customized biomedical filed (Figure 1).…”